Related Experiment Videos
Memory enhancing effects of granisetron (BRL 43694) in a passive avoidance task
Y Chugh1, N Saha, A Sankaranarayanan
1Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
European Journal of Pharmacology
|October 2, 1991
Summary
The 5-HT3 receptor antagonist granisetron enhances memory in mice by improving learning, retention, and retrieval. This suggests non-cholinergic treatments may offer new avenues for memory enhancement.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Serotonin (5-HT) is increasingly recognized for its role in animal learning and memory.
- Understanding the specific mechanisms of serotonin in memory is crucial for developing therapeutic interventions.
Purpose of the Study:
- To investigate the impact of the 5-HT3 receptor antagonist, granisetron, on the acquisition, retention, and retrieval of a passive avoidance response in mice.
- To explore the potential of non-cholinergic agents for memory enhancement.
Main Methods:
- Mice were administered varying doses of granisetron (1, 10, 100 µg/kg) at different time points relative to a footshock stimulus.
- A passive avoidance task was used to assess learning and memory, measuring step-down latency.
- Testing occurred at 24 hours and immediately after/23.5 hours post-footshock to evaluate different memory phases.
Main Results:
- Granisetron (1 and 10 µg/kg) administered before footshock significantly increased step-down latency 24 hours later, indicating enhanced retention.
- Doses of 10 and 100 µg/kg administered immediately after or 23.5 hours post-footshock also increased latency, suggesting effects on retrieval and consolidation.
- Acquisition was not significantly affected by a 100 µg/kg dose, and low-dose granisetron (1 µg/kg) showed no significant memory effects.
Conclusions:
- The findings support a significant role for serotonin in learning and memory processes.
- Granisetron demonstrates potential as a memory-enhancing agent, particularly through its modulation of 5-HT3 receptors.
- This study highlights the therapeutic potential of non-cholinergic treatments for cognitive disorders.